TriSalus Life Sciences (TLSIW) Return on Invested Capital (2022 - 2026)

TriSalus Life Sciences (TLSIW) has 5 years of Return on Invested Capital data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital fell 11.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (down 11.0% YoY), and the FY2025 full-year result was 0.12%, up 9.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.01%, up from 0.1% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.31% in Q3 2024 and bottomed at 0.1% in Q4 2025.
• The 5-year median for Return on Invested Capital is 0.0% (2023), against an average of 0.04%.
• The widest annual swing landed in 2024, when Return on Invested Capital surged 31 bps; it then tumbled 39 bps in 2025.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then soared by 4465 bps to 0.06% in 2023, then jumped by 386 bps to 0.28% in 2024, then plunged by 137 bps to 0.1% in 2025, then surged by 88 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.1% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.

Peer Comparison